NCDP--Nicodrops (NCDP)

[Gd2Aussie3]

Nicodrops Responds to Charges by GlaxoSmithKline Consumer Healthcare

LA MESA, Calif., Feb. 9, 2005 (PRIMEZONE) -- Nicodrops International Inc., a subsidiary of Nicodrops, Inc. (Pink Sheets:NCDP), developer of the world's first drug-free, non-nicotine smoking cessation lozenge, today announced it is standing behind its Nicodrops product and will aggressively defend a lawsuit filed yesterday by GlaxoSmithKline Consumer Healthcare (NYSE:GSK) in Federal district court in Western District of Pennsylvania. The suit seeks to prevent Nicodrops from using its name and providing its products to people who desire to stop smoking by attacking the efficacy on Nicodrops products.

"The suit filed by GlaxoSmithKline has absolutely no basis to it," said Christopher Calpito, president and CEO of Nicodrops, Inc. "Nicodrops looks forward to dealing with it in court. We are intent on vigorously defending our company and its products. Nicodrops is also closely examining the comments about nicodrops in yesterday's press release announcing the suit made by the president of GSK Consumer Healthcare North America."

About Nicodrops

Nicodrops, Inc., headquartered in La Mesa, CA, has developed the world's first drug free, non-nicotine product which is an aid to smokers wishing to give up their habit faster and at a lower cost than their major competitors without the adverse effects of nicotine. Nicodrops is an all-natural herb lozenge which helps to calm the nervous anxiety that is brought on by nicotine addiction. The company's lozenge products are based on patent protected proprietary technology which offers a safer alternative to all other nicotine based products in the marketplace today.

About GlaxoSmithKline Consumer Healthcare

GlaxoSmithKline Consumer Healthcare is one of the world's largest over- the-counter healthcare products companies. Its more than 30 well-known brands include the leading smoking cessation products, Nicorette and NicoDerm and Commit, as well as many medicine cabinet staples, Abreva(R), Aquafresh(R), Sensodyne(R) and Tums(R). GSK Consumer Healthcare continues to develop innovative products to help all smokers find their best support system and achieve their goal of being cigarette free.


CONTACT: Cervelle Group
David Donlin
[phone]
[e-mail]


20050209
http://aolsvc.news.aol.com/business/article.adp?id=20050209130609990009

Have a g'day.

Aussie